⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

IRD News

Opus Genetics, Inc. Common Stock

Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)